Arterial hypertension is a very common disease and an important risk factor for cardiovascular disease. Patients with arterial hypertension are characterized by functional and structural vascular abnormalities.
Vascular endothelium plays a fundamental role in modulating vascular tone and structure. The physiological production of the relaxing factors including nitric oxide, prostacyclin and hyperpolarizing relaxing factors protects the vessel wall by antagonizing the first pathogenetic steps of atherosclerosis and thrombosis. Endothelial cells may also produce endothelium-derived contracting factors. The principal component of these contracting factors is endothelin-1, which promotes the growth of the smooth muscle cells and has a vasoconstrictive and blood pressure raising effect. Defective nitric oxide production is already detectable in normotensive offspring of hypertensive patients and young essential hypertensives. A dysfunctional endothelium due to reduced nitric oxide availability associated with an increased production of oxidative stress and vasoconstricting factors is considered as an early indicator of atherothrombotic damage and of cardiovascular events also in patients with arterial hypertension. Moreover, patients with arterial hypertension are also characterized by increased arterial stiffness. This parameter, known as a sign of cardiovascular risk since the 19th century, has been shown to be a predictor of adverse cardiovascular outcome and its measurement in hypertensive patients is suggested by the European guidelines for the diagnosis and treatment of hypertension.
Keywords: Essential hypertension, endothelium, nitric oxide, arterial stiffness, oxidative stress, vascular smooth muscle, thrombosis, cyclooxygenase (COX), arachidonic acid, prostacyclin
Hypertension and Cardiac Arrhythmias
Current Pharmaceutical Design Regular Physical Activity and Vascular Aging
Current Pharmaceutical Design Drug-drug Interactions of Angiotensin Converting Enzyme Inhibitors Mediated by Metabolizing Enzymes and Transporters
Current Drug Metabolism Development of Inhibitors of the Aspartyl Protease Renin for the Treatment of Hypertension
Current Protein & Peptide Science Cortical and Putamen Age-Related Changes in the Microvessel Density and Astrocyte Deficiency in Spontaneously Hypertensive and Stroke-Prone Spontaneously Hypertensive Rats
Current Neurovascular Research Structure-activity Relationship of Chemical Penetration Enhan-cers in Transdermal Drug Delivery
Current Medicinal Chemistry Nutrition and Physical Activity on Hypertension: Implication of Current Evidence and Guidelines
Current Hypertension Reviews Myocardial Insulin Resistance and Cardiac Complications of Diabetes
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Silent Partner in Blood Vessel Homeostasis? Pervasive Role of Nitric Oxide in Vascular Disease
Current Hypertension Reviews Matrix Metalloproteinases as Drug Targets in Acute Pulmonary Embolism
Current Drug Targets Is Mania the Hypertension of the Mood? Discussion of A Hypothesis
Current Neuropharmacology Oxidative-Nitrosative Stress In Hypertension
Current Vascular Pharmacology Neurovascular Mechanisms of Hypertension in Pregnancy
Current Neurovascular Research Oxidative Stress and Endothelial Dysfunction in Cardiovascular Disease: Mitochondria-Targeted Therapeutics
Current Medicinal Chemistry Management of Prehypertension: Current Status and Future Strategies
Current Hypertension Reviews Microvascular Alterations in Hypertension and Vascular Aging
Current Hypertension Reviews Insights into the Relationship Between Hypertension and Albuminuria
Current Hypertension Reviews Effects of Obesity on Vascular Potassium Channels
Current Vascular Pharmacology Pre-eclampsia Versus Cardiovascular Disease Versus CRP
Current Hypertension Reviews Is Hypertension an Inflammatory Process?
Current Pharmaceutical Design